Pillai G, Brown N A, McAllister G, Milligan G, Seabrook G R
Merck Sharp and Dohme, Neuroscience Research Centre, Harlow, UK.
Neuropharmacology. 1998 Aug;37(8):983-7. doi: 10.1016/s0028-3908(98)00092-6.
To examine the effects of a novel selective D4 receptor ligand, L-745,870 (3-[4-(4-chlorophenyl)piperazin-1-yl]methyl-1H-pyrrolo[2,3-b]pyrid ine), on human dopamine receptor function, the ability of this ligand to antagonise G-protein gated inwardly rectifying K+ (GIRK/Kir3) currents activated by cloned human D2 and D4 receptors expressed in Xenopus oocytes was examined using voltage-clamp recording. Its effects were also contrasted with that of a selective D2 receptor antagonist L-741,626. L-745,870 had no detectable agonist activity on human D4 receptors and selectively blocked currents activated by D4 but not D2 receptors. The role of G-protein subunits in dopamine receptor modulation of GIRK currents was also examined by co-expression of beta1 and/or gamma2 subunits on spontaneously active and receptor-activated currents. Currents activated by both D2 and D4 receptors were occluded by direct activation of GIRK currents following co-transfection with the cDNA encoding G-protein betagamma subunits. These data demonstrate that L-745,870 and L-741,626 act as antagonists on human D4 and D2 receptors respectively, and that activation of GIRK channels by these dopamine receptors can be disrupted by direct stimulation of K+ currents by G-protein betagamma subunits.
为研究新型选择性D4受体配体L-745,870(3-[4-(4-氯苯基)哌嗪-1-基]甲基-1H-吡咯并[2,3-b]吡啶)对人多巴胺受体功能的影响,采用电压钳记录法检测了该配体拮抗非洲爪蟾卵母细胞中克隆表达的人D2和D4受体激活的G蛋白门控内向整流钾离子(GIRK/Kir3)电流的能力。还将其作用与选择性D2受体拮抗剂L-741,626的作用进行了对比。L-745,870对人D4受体无明显激动活性,且能选择性阻断D4而非D2受体激活的电流。通过共表达β1和/或γ2亚基对自发激活电流和受体激活电流进行研究,还检测了G蛋白亚基在多巴胺受体对GIRK电流调节中的作用。与编码G蛋白βγ亚基的cDNA共转染后,通过直接激活GIRK电流,可阻断D2和D4受体激活的电流。这些数据表明,L-745,870和L-741,626分别作为人D4和D2受体的拮抗剂,且G蛋白βγ亚基直接刺激钾离子电流可破坏这些多巴胺受体对GIRK通道的激活。